معرفی
Dr Chris J H Elliott is a Lecturer in the Department of Biology at the University of York, specializing in Parkinson's disease research using Drosophila models. His work investigates genetic mechanisms of neurodegeneration and develops novel physiological assays to study early disease progression in dopaminergic neurons.
His research focuses on how mutations in Parkinson's-associated genes (parkin, PINK1, DJ1, LRRK2) cause neuronal death through mitochondrial dysfunction and energy deficits. He has demonstrated that LRRK2 mutations induce visual system degeneration in flies, which can be rescued by kinase inhibitors including Vitamin B12. His lab bridges molecular genetics with whole-organism physiology to identify therapeutic targets.
Recent publications (2020-2025) reveal consistent themes: LRRK2-Rab GTPase interactions in dopaminergic pathways, glial-mediated neuroprotection mechanisms, and mitochondrial chaperone roles in neurodegeneration. His work uniquely combines genetic manipulation with functional assays like visual response and proboscis extension to model disease progression.
Dr Elliott actively supervises PhD students on Parkinson's projects and has secured internal University of York grants including CFH1 Priming (circadian vision monitoring), RPF 2015/16 (respiration measurement), and vision testing in Parkinson's flies. His interdisciplinary approach integrates physiology, genetics, and drug screening.
He leads a Drosophila research group developing novel assays for bradykinesia and visual function. His team collaborates across departments to study kinase inhibitors, mitochondrial dynamics, and neuroprotective compounds, maintaining strong links with Parkinson's UK and clinical researchers.
